Oncology Central

Urine-based test for detection of colonic polyps: the coming of age


Metabolomic-based tests for colorectal cancer

For an individual aged 50–74 years without a family or personal history of colorectal cancer, current population-based screening tools consist of a combination of a stool tests and/or a diagnostic imaging study. If colonic polyps are identified, these are then removed via colonoscopy. Each of these tests and combinations have advantages and limitations, the most important of which is the well-documented limited compliance with stool testing by individuals in addition to its limited diagnostic sensitivity. More recently, the concept of using a blood or urine metabolomics test to replace the stool test for detecting colonic polyps or cancer has been introduced and discussed in the literature [1].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.